Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lincoln Electric | LECO | Jan 17, 2025 | 194.32 | +0.09 |
Lincoln National | LNC | Jan 17, 2025 | 33.13 | +1.35 |
Lincoln National Pref | LNC-D | Jan 17, 2025 | 27.38 | -0.65 |
Lindblad Expeditions | LIND | Jan 17, 2025 | 12.16 | +5.56 |
Linde | LIN | Jan 17, 2025 | 436.00 | +0.81 |
Lindsay | LNN | Jan 17, 2025 | 133.04 | +1.34 |
Lineage | LINE | Jan 17, 2025 | 58.18 | +1.34 |
Lineage Cell Therapeutics | LCTX | Jan 17, 2025 | 0.59 | +2.80 |
Linkage Global A | LGCB | Jan 17, 2025 | 0.29 | -22.27 |
Linkbancorp | LNKB | Jan 17, 2025 | 7.28 | +0.41 |
Linkers Industries | LNKS | Jan 17, 2025 | 0.94 | 0.00 |
Lion ADR | LGHL | Jan 17, 2025 | 0.16 | -0.62 |
Lionheart Units | CUBWU | Jan 17, 2025 | 10.02 | 0.00 |
Lions Gate Entertainment A | LGF-A | Jan 17, 2025 | 7.55 | +0.94 |
Lions Gate Entertainment B | LGF-B | Jan 17, 2025 | 6.73 | +0.60 |
Lipella Pharmaceuticals | LIPO | Jan 17, 2025 | 2.85 | -2.40 |
Lipocine | LPCN | Jan 17, 2025 | 4.37 | -1.80 |
LiqTech International | LIQT | Jan 17, 2025 | 1.81 | +1.12 |
Liquidia | LQDA | Jan 17, 2025 | 12.89 | +3.04 |
Liquidity Services | LQDT | Jan 17, 2025 | 34.56 | +0.32 |
Lisata Therapeutics | LSTA | Jan 17, 2025 | 3.71 | -0.27 |
Lithia Motors | LAD | Jan 17, 2025 | 352.35 | -1.60 |
Lithium Americas | LAC | Jan 17, 2025 | 3.49 | +1.45 |
Lithium Americas (Argentina) | LAAC | Jan 17, 2025 | 3.00 | +0.33 |
Littelfuse | LFUS | Jan 17, 2025 | 233.17 | +0.88 |
LivaNova | LIVN | Jan 17, 2025 | 48.30 | +0.67 |
Live Nation Entertainment | LYV | Jan 17, 2025 | 135.61 | +1.53 |
Live Oak Bancshares | LOB | Jan 17, 2025 | 40.66 | +1.78 |
Live Ventures | LIVE | Jan 17, 2025 | 9.50 | +2.04 |
LiveOne | LVO | Jan 17, 2025 | 1.18 | +0.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.